Close Menu

NEW YORK (GenomeWeb) – BG Medicine said in its most recent 10K filing that laboratory firm True Health Diagnostics (THD) has declined to assume a supply agreement for BG's galectin-3 tests.

The agreement was originally established between BG and Health Diagnostics Laboratory (HDL), which filed for bankruptcy in June 2015. THD last year acquired the assets of HDL, which was formerly BG's largest customer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.